(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity

(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White to Pale Yellow Solid

Verwenden

FK-506 (F370000) impurity. A new macrolite of thermal rearrangement of the immunosuppressant FK-506.

(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28180	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11927	58
Scinova Biotech(Guangzhou) Co., Ltd.	13268215580	scinova_sales@163.com	China	7026	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736 15347293736	2853117764@qq.com	China	8527	58
Nanning Saifir Biotechnology Co., Ltd.	18877121284	1309367106@qq.com	China	259	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	94717	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32344	50
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14059	65
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8073	58

---

• [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-
• Tacrolimus Impurity 13 （Positional Isomer ）
• 17,21-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclopentacosine-1,9,22,23(6H,25H)-tetrone, 7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-, [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,1...
• [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-Hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-7,21-epo
• Tacrolimus Impurity 21
• Tacrolimus Impurity 2
• Tacrolimus Rearrangement Lactone
• 17,21-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclopentacosine-1,9,22,23(6H,25H)-tetrone, 7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-, [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-
• Tacrolimus Impurity 29
• (E/Z)-FK-506 26,28-Allylic Ester Rearrangement Impurity
• Tacrolimus Impurity 36
• (E/Z)-FK-506 26,28-Allylic Ester Rearrangemen
• 131944-48-4
• Chiral Reagents, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
• Chiral Reagents
• Impurities
• Intermediates & Fine Chemicals
• Pharmaceuticals